RheocalcT Software Tests Parameters and Data Collection - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

RheocalcT Software Tests Parameters and Data Collection


Pharmaceutical Technology
Volume 37, Issue 10, pp. 18
Untitled Document

RheocalcT Software allows the operator to automate viscosity testing from a PC when using the DV3T Touch Screen Rheometer and the DV2T Touch Screen Viscometer. The user interface for RheocalcT has a range of choices for test method creation and data gathering/analysis.  Loop functions allow performance of repetitive tasks on test samples that require viscosity measurement at multiple rotational speeds, different temperature set points, and discreet time intervals.  Viscosity data averaging is possible for individual tasks within a test step or over multiple steps in the total test program.  Advanced data analysis to assess yield stress and pseudo plastic index can be performed with a choice of math models: Bingham, Casson, NCA/CMA Casson, Power Law, IPC Paste, and Herschel-Bulkley.

Brookfield Engineering

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here